ELIXIRR INTERNATIONAL PLC financials
ELIXIRR INTERNATIONAL PLC
213800MKY7OHMVAKW681 | Line item | 2025 | 2024 |
|---|---|---|
| Income statement | ||
| Revenue | £149.6M | £111.3M |
| Cost of sales | £99.9M | £75.5M |
| Gross profit | £49.7M | £35.8M |
| Administrative expenses | £17.7M | £11.0M |
| Depreciation & amortisation | £5.5M | £2.4M |
| Operating profit (EBIT) | £29.7M | £23.7M |
| Net finance income / (cost) | -£2.1M | -£804.0K |
| Finance costs | £2.3M | £1.2M |
| Profit before tax | £27.6M | £22.9M |
| Income tax expense | £7.9M | £6.5M |
| Profit for the year | £19.7M | £16.4M |
| Total comprehensive income | £15.3M | £17.5M |
| Per share | ||
| Basic EPS | £0.41 | £0.35 |
| Diluted EPS | £0.37 | £0.32 |
| Free cash flow / share | £0.62 | £0.57 |
| Cash flow statement | ||
| Cash generated from operations | £40.0M | £35.5M |
| Net cash from operating activities | £33.0M | £29.4M |
| Net cash from investing activities | -£36.5M | -£21.1M |
| Purchase of PP&E (capex) | £73.0K | £84.0K |
| Purchase of intangibles | £131.0K | £242.0K |
| Net cash from financing activities | £1.4M | -£18.6M |
| Dividends paid | £8.4M | £6.9M |
| Proceeds from borrowings | £60.0M | £13.7M |
| Repayments of borrowings | £31.4M | £14.4M |
| Lease liability payments | £1.5M | £1.1M |
| Net change in cash | -£2.1M | -£10.3M |
| Balance sheet | ||
| Total assets | £251.1M | £174.4M |
| Non-current assets | £218.5M | £148.0M |
| Property, plant & equipment | £4.2M | £4.9M |
| Intangible assets & goodwill | £197.3M | £128.8M |
| Current assets | £32.6M | £26.4M |
| Trade & other receivables | £26.8M | £18.4M |
| Cash & equivalents | £5.1M | £7.5M |
| Total equity | £142.5M | £132.1M |
| Non-current liabilities | £45.3M | £9.5M |
| Long-term borrowings | £22.9M | £3.4M |
| Current liabilities | £63.2M | £32.8M |
| Trade & other payables | £30.3M | £25.7M |
| Deferred tax liabilities | £666.0K | £833.0K |
| Derived metrics | ||
| Free cash flow | £32.9M | £29.3M |
| Operating margin | 19.9% | 21.3% |
| Net margin | 13.2% | 14.7% |
| Return on equity | 13.8% | 12.4% |
| Cash conversion ratio | 1.68× | 1.79× |
| Capex coverage | 452.14× | 349.98× |
| Other reported items | ||
| Capital Redemption Reserve | £2.0K | £2.0K |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | £36.4M | £21.2M |
| Current Assets Liabilities | -£30.6M | -£6.4M |
| Current Borrowings and Current Portion of Noncurrent Borrowings | £10.6M | £1.5M |
| Current Tax Assets | £716.0K | £467.0K |
| Current Tax Liabilities | £0 | £0 |
| Current Tax Relating To Items Charged Or Credited Directly To Equity | £1.9M | £1.4M |
| Deferred Tax Assets | £4.7M | £3.8M |
| Deferred Tax Relating To Items Charged Or Credited Directly To Equity | £7.0K | -£156.0K |
| Depreciation Expense | £1.7M | £1.5M |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners | £7.5M | — |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners Per Share | £0.15 | — |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -£376.0K | -£307.0K |
| Expense From Sharebased Payment Transactions With Employees | £5.0M | £2.5M |
| Finance Income | £162.0K | £394.0K |
| Income Taxes Paid Refund Classified As Operating Activities | £7.0M | £6.1M |
| Increase Decrease Through Sharebased Payment Transactions | £4.0M | £2.0M |
| Interest Paid Classified As Financing Activities | £249.0K | £288.0K |
| Interest Received Classified As Investing Activities | £41.0K | £394.0K |
| Investments In Subsidiaries | £0 | £0 |
| Issue of Equity | £11.7M | £6.4M |
| Issued Capital | £52.0K | £52.0K |
| Liabilities | £108.6M | £42.3M |
| Merger Reserve | £46.9M | £46.9M |
| Net Assets Liabilities | £142.5M | £132.1M |
| Noncurrent Loans and Receivables | £8.6M | £7.4M |
| Other Comprehensive Income | -£4.4M | £1.1M |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | -£4.4M | £1.1M |
| Other Current Payables | £22.3M | £5.6M |
| Other Noncurrent Liabilities | £21.7M | £5.3M |
| Other Noncurrent Receivables | £3.7M | £3.0M |
| Payments To Acquire Or Redeem Entitys Shares | £20.7M | £12.2M |
| Proceeds From Sale Or Issue of Treasury Shares | £7.0M | £4.1M |
| Purchase of Treasury Shares | £23.9M | £12.1M |
| Reserve of Exchange Differences On Translation | -£2.9M | £1.5M |
| Retained Earnings | £57.1M | £52.9M |
| Sale Or Issue of Treasury Shares | £9.8M | £4.4M |
| Share Premium | £45.4M | £33.7M |
| Treasury Shares | £4.0M | £2.9M |
Every line item above is a fact tagged in ELIXIRR INTERNATIONAL PLC's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (GBP), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.